Merck Sharp & Dohme Corp v. Mylan Pharmaceuticals Inc
Merck Sharp & Dohme Corp v. Mylan Pharmaceuticals Inc is a federal patent lawsuit filed on 08/09/2019 in the District Court, D. Delaware. The case was terminated on 08/30/2021.
- Court
- District Court, D. Delaware (D. Del.)
Official Court Website → - Assigned judge
- Richard G. Andrews · 4,097 cases in index
- Docket number
- 1:19-cv-01489
- Cause
- 35:271 Patent Infringement
35 U.S.C. § 271 — Patent infringement - Nature of suit
- 830 Patent
Infringement of a patented invention. - Jurisdiction
- Federal Question
- Jury demand
- None
- Date filed
- 08/09/2019
- Date terminated
- 08/30/2021
11,768 Patent cases in this court are indexed here.
Parties
- plaintiff · Merck & Co., Inc Pharmaceuticals & Biotechnology · 24169 cases
- defendant · Mylan Pharmaceuticals Inc · 388 cases
Part of a Larger Litigation Pattern
This is one of 389 Patent cases in our index naming MYLAN PHARMACEUTICALS INC — a possible mass-tort or coordinated-litigation cluster.
About Patent Lawsuits
Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.
Frequently Asked Questions
What is Merck Sharp & Dohme Corp v. Mylan Pharmaceuticals Inc?
Merck Sharp & Dohme Corp v. Mylan Pharmaceuticals Inc is a federal patent lawsuit filed on 08/09/2019 in the District Court, D. Delaware. The case was terminated on 08/30/2021. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.
What type of case is this?
It is classified as “Patent” under the federal nature-of-suit system. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.
What court is the case in?
The case is in the District Court, D. Delaware, docket number 1:19-cv-01489.
When was the case filed?
Merck Sharp & Dohme Corp v. Mylan Pharmaceuticals Inc was filed on 08/09/2019. It was terminated on 08/30/2021.
What law is the case brought under?
The docket lists the cause as 35 U.S.C. § 271 — Patent infringement.
Other Cases Involving These Parties
Related Patent Cases
Source: public U.S. federal court record (docket 16039372).